US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology Industry Research & Market Reports

1  2  3  4    6    8  9  10  
Scientific Research and Development (R&D) Industry, in Life Sciences, Medical Devices, Biotechnology and Pharmaceuticals (Drugs) Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2022, NAIC 541711
6/29/2015 | published by: Plunkett Research, Ltd.
... benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Scientific Research and Development (R&D) Industry, in Life Sciences, Medical Devices, Biotechnology and Pharmaceuticals (Drugs) Industry (U.S.) to reach ...  |  read more...
USD 1,995
Germany Bioinformatics Market Forecast and Opportunities, 2020
7/1/2015 | published by: TechSci Research
... driving the country’s bioinformatics market. Mounting demand for innovative medical solutions for treatment of diseases, decoding genetic constitution of an organism, studying climatic changes, rising use of microbial genome information for waste clean-up, antibiotic resistance, ...  |  read more...
USD 2,200
Transfection Reagents and Equipment Market by Method (Biochemical (Calcium Phosphate, Lipofection, Dendrimers), Physical (Electroporation, Nucleofection), Viral) & by Application (Biomedical, Protein Production) - Analysis & Global Forecast to 2020
7/1/2015 | published by: MarketsandMarkets
... reagents and equipment market has witnessed various technological advancements in equipment as well as reagents to address the requirements of researchers and biotechnology and biopharmaceutical companies. These advancements have led to the development of transfection ...  |  read more...
USD 4,650
Biotech Business January 2015
7/1/2015 | published by: Worldwide Videotex
... on biotechnology products and companies. It reports which universities offer licensing of biotechnology research, which companies have entered licensing agreements, as well as the financial health of biotechnology companies and their expected growth or decline.  |  read more...
USD 25
genOway SA (ALGEN) - Financial and Strategic SWOT Analysis Review
6/16/2015 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Osiris Therapeutics, Inc. (OSIR) - Financial and Strategic SWOT Analysis Review
6/16/2015 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
Vical Incorporated (VICL) - Financial and Strategic SWOT Analysis Review
6/16/2015 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
XOMA Corporation - Product Pipeline Review - 2015
6/17/2015 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of XOMA Corporation’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Anika Therapeutics Partnering 2010-2015
7/1/2015 | published by: Current Partnering
... better understand Anika Therapeutics and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company ...  |  read more...
USD 1,495
Oxford Gene Technology - Product Pipeline Analysis, 2015 Update
6/24/2015 | published by: GlobalData
... Solid Tumour Panel for clinical genetics researchCytoSure Medical Research Exome Array, Embryo Screen Array, ISCA and ISCA +SNP Arrays, Aneuploidy Array, Chromosome X Arrays and CytoSure Molecular Arrays for clinical molecular genetics research. In addition ...  |  read more...
USD 750
Biotech Equipment Update January 2015
7/1/2015 | published by: Worldwide Videotex
Biotech Equipment Update covers news and the latest information about biotechnology lab and manufacturing equipment and products. This includes new product and technology announcements, as well as vendor research, development, and manufacturing information.  |  read more...
USD 25
Celgene Partnering 2010-2015
7/1/2015 | published by: Current Partnering
... are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying their interests and making ...  |  read more...
USD 1,495
Elan Partnering 2010-2015
7/1/2015 | published by: Current Partnering
... understand Elan and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and company data. The ...  |  read more...
USD 1,495
Gilead Sciences Partnering 2010-2015
7/1/2015 | published by: Current Partnering
... that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying their interests and ...  |  read more...
USD 1,495
2015-2019 World Tumor Marker Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - France, Germany, Italy, Japan, Spain, UK, US
6/26/2015 | published by: VPGMarketResearch.com
... The report examines trends in the U.S., Europe and Asia; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading ...  |  read more...
USD 34,750
Future Horizons and Growth Strategies in the French Hospital Tumor Marker Testing Market 2015: Supplier Shares and Country Forecasts
6/16/2015 | published by: VPGMarketResearch.com
... key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, ...  |  read more...
USD 3,850
Future Horizons and Growth Strategies in the Italian Hospital Tumor Marker Testing Market 2015: Supplier Shares and Country Forecasts
6/16/2015 | published by: VPGMarketResearch.com
... key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, ...  |  read more...
USD 3,850
Future Horizons and Growth Strategies in the Spanish Hospital Tumor Marker Testing Market 2015: Supplier Shares and Country Forecasts
6/16/2015 | published by: VPGMarketResearch.com
... key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, ...  |  read more...
USD 3,850
Future Horizons and Growth Strategies in the UK Hospital Tumor Marker Testing Market 2015: Supplier Shares and Country Forecasts
6/16/2015 | published by: VPGMarketResearch.com
... key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, ...  |  read more...
USD 3,850
Future Horizons and Growth Strategies in the US Hospital Tumor Marker Testing Market 2015: Supplier Shares and Country Forecasts
6/16/2015 | published by: VPGMarketResearch.com
... economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, ...  |  read more...
USD 6,500
Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2019 - Strategic Analysis of Industry Trends, Technologies, Participants, and Environment
7/1/2015 | published by: Kelly Scientific Publications
... influential technologies, and business and economic environments. The report is supported by over 317 tables & figures over 279 pages. The personalized medicine (global & USA) market is presented as follows: By Company (e.g., Qiagen, ...  |  read more...
USD 3,400
Antibodies in Oncology Drug Pipeline Update 2015
6/17/2015 | published by: BioSeeker Group AB
... for the second wave in the lucrative field of therapeutic antibodies. There are today 490 companies plus partners developing 1039 antibody drugs in 2692 developmental projects in cancer. In addition, there are 6 suspended drugs ...  |  read more...
USD 6,750
Cancer Stem Cells Drug Pipeline Update 2015
6/17/2015 | published by: BioSeeker Group AB
... development and cancer drugs which are inhibitors of the Hedgehog, Notch, and WNT Pathway. These developmental pathways are frequently activated in neoplasms, and particularly in the rare subpopulation of cancer stem cells. There are today ...  |  read more...
USD 6,750
Gene Therapy in Oncology Drug Pipeline Update 2015
6/17/2015 | published by: BioSeeker Group AB
... the accumulated number of ceased drugs over the last years amount to another 103 drugs. Gene Therapy In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of ...  |  read more...
USD 6,750
Proteins in Oncology Drug Pipeline Update 2015
6/17/2015 | published by: BioSeeker Group AB
... 944 developmental projects in cancer. In addition, there are 2 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 201 drugs. Proteins In Oncology Drug Pipeline Update lists ...  |  read more...
USD 6,750
1  2  3  4    6    8  9  10